• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

眼表鳞状上皮肿瘤:新西兰怀卡托地区发病率的12个月前瞻性评估

Ocular Surface Squamous Neoplasia: A 12-Month Prospective Evaluation of Incidence in Waikato, New Zealand.

作者信息

Hossain Ruhella R, Oh Jee Ah, McLintock Cameron, Murphy Chris, McKelvie James

机构信息

Department of Ophthalmology, Faculty of Medical and Health Sciences, University of Auckland, Auckland 1010, New Zealand.

Department of Ophthalmology, Hawkes Bay District Health Board, Hastings 4120, New Zealand.

出版信息

Vision (Basel). 2022 Aug 12;6(3):50. doi: 10.3390/vision6030050.

DOI:10.3390/vision6030050
PMID:35997381
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9397019/
Abstract

Ocular surface squamous neoplasia (OSSN) has a high incidence in the southern hemisphere. This prospective study evaluated the incidence of OSSN in the Waikato region of New Zealand. All patients presenting with pterygium or conjunctival lesions in the Waikato region in 2020 were included. All surgeons in the region were asked to send all conjunctival and corneal specimens excised for histopathologic examination. The primary outcome measure was the incidence of OSSN. Eighty-eight percent of all excised specimens were sent for histopathologic examination. Of the 185 excised lesions sent for histopathological assessment, 18 (10%) were reported as OSSN. Patients were on average 69.4 years of age (standard deviation, SD = 6.9), predominantly male (78%), and of New Zealand-European ethnicity (89%). The OSSN annual incidence was 3.67/100,000/year. Histology grades included conjunctival intraepithelial neoplasia (CIN)-I (25%), CIN-II (25%), CIN-III (12.5%), carcinoma in situ (25%), and invasive squamous cell carcinoma (SCC) (12.5%). One patient with invasive SCC required exenteration. This study identified a high incidence rate of OSSN and is the first prospective study to analyze OSSN epidemiology in New Zealand.

摘要

眼表鳞状上皮肿瘤(OSSN)在南半球发病率较高。这项前瞻性研究评估了新西兰怀卡托地区OSSN的发病率。纳入了2020年在怀卡托地区出现翼状胬肉或结膜病变的所有患者。该地区所有外科医生均被要求将所有切除的结膜和角膜标本送去做组织病理学检查。主要观察指标是OSSN的发病率。所有切除标本的88%被送去做组织病理学检查。在送去做组织病理学评估的185个切除病变中,有18个(10%)被报告为OSSN。患者平均年龄为69.4岁(标准差,SD = 6.9),以男性为主(78%),且为新西兰欧洲族裔(89%)。OSSN的年发病率为3.67/10万/年。组织学分级包括结膜上皮内瘤变(CIN)-I(25%)、CIN-II(25%)、CIN-III(12.5%)、原位癌(25%)和浸润性鳞状细胞癌(SCC)(12.5%)。1例浸润性SCC患者需要进行眼球摘除术。本研究确定了OSSN的高发病率,并且是第一项分析新西兰OSSN流行病学的前瞻性研究。

相似文献

1
Ocular Surface Squamous Neoplasia: A 12-Month Prospective Evaluation of Incidence in Waikato, New Zealand.眼表鳞状上皮肿瘤:新西兰怀卡托地区发病率的12个月前瞻性评估
Vision (Basel). 2022 Aug 12;6(3):50. doi: 10.3390/vision6030050.
2
Ocular surface squamous neoplasia in New Zealand: a ten-year review of incidence in the Waikato region.新西兰眼表鳞状细胞肿瘤:怀卡托地区十年发病率回顾。
Eye (Lond). 2022 Aug;36(8):1567-1570. doi: 10.1038/s41433-021-01662-3. Epub 2021 Jul 14.
3
Ocular Surface Squamous Neoplasia眼表鳞状上皮肿瘤
4
[Histopathology manifestation and imaging characteristics of confocal microscopy for diagnosis of ocular surface squamous neoplasia].共聚焦显微镜诊断眼表鳞状上皮肿瘤的组织病理学表现及影像学特征
Zhonghua Yan Ke Za Zhi. 2018 Sep 11;54(9):652-660. doi: 10.3760/cma.j.issn.0412-4081.2018.09.004.
5
High frequency of squamous intraepithelial neoplasia in pterygium related to low ultraviolet light exposure.与低紫外线暴露相关的翼状胬肉中鳞状上皮内瘤变的高发生率。
Saudi J Ophthalmol. 2016 Apr-Jun;30(2):113-6. doi: 10.1016/j.sjopt.2016.02.007. Epub 2016 Mar 10.
6
Predictors of Ocular Surface Squamous Neoplasia and Conjunctival Squamous Cell Carcinoma among Ugandan Patients: A Hospital-based Study.乌干达患者眼表鳞状上皮瘤和结膜鳞状细胞癌的预测因素:一项基于医院的研究。
Middle East Afr J Ophthalmol. 2018 Jul-Dec;25(3-4):150-155. doi: 10.4103/meajo.MEAJO_187_16.
7
Incidence of ocular surface squamous neoplasia in pterygium specimens.翼状胬肉标本中眼表鳞状上皮肿瘤的发生率。
Can J Ophthalmol. 2024 Apr;59(2):79-82. doi: 10.1016/j.jcjo.2022.12.004. Epub 2023 Jan 4.
8
Variable presentations of six conjunctival/limbal ocular surface squamous neoplasia (OSSN) cases: How good is our clinical judgment evidenced by the correlation to the histopathological findings and diagnosis?6例结膜/角膜缘眼表鳞状上皮肿瘤(OSSN)的不同表现:通过与组织病理学结果和诊断的相关性来证明我们的临床判断有多准确?
Int J Surg Case Rep. 2024 Mar;116:109359. doi: 10.1016/j.ijscr.2024.109359. Epub 2024 Feb 6.
9
Ultra-high resolution optical coherence tomography for differentiation of ocular surface squamous neoplasia and pterygia.用于区分眼表鳞状上皮肿瘤和翼状胬肉的超高分辨率光学相干断层扫描。
Ophthalmology. 2012 Mar;119(3):481-6. doi: 10.1016/j.ophtha.2011.08.028. Epub 2011 Dec 9.
10
Bilateral ocular surface squamous neoplasia: A study of 25 patients and review of literature.双侧眼表鳞状细胞肿瘤:25 例患者的研究及文献回顾。
Eur J Ophthalmol. 2022 Jan;32(1):620-627. doi: 10.1177/11206721211007109. Epub 2021 Apr 5.

引用本文的文献

1
Clinicopathological Correlates of Ocular Surface Squamous Neoplasia.眼表鳞状上皮肿瘤的临床病理相关性
Ocul Oncol Pathol. 2024 Jun;10(2):88-97. doi: 10.1159/000538174. Epub 2024 Apr 5.

本文引用的文献

1
Ocular surface squamous neoplasia in New Zealand: a ten-year review of incidence in the Waikato region.新西兰眼表鳞状细胞肿瘤:怀卡托地区十年发病率回顾。
Eye (Lond). 2022 Aug;36(8):1567-1570. doi: 10.1038/s41433-021-01662-3. Epub 2021 Jul 14.
2
Ocular surface squamous neoplasia: management and outcomes.眼表鳞状细胞肿瘤:治疗与结局。
Eye (Lond). 2021 Jun;35(6):1562-1573. doi: 10.1038/s41433-021-01422-3. Epub 2021 Feb 9.
3
Observational study of ocular surface squamous neoplasia: Risk factors, diagnosis, management and outcomes at a tertiary eye hospital in South Africa.南非一家三级眼科医院的眼表鳞状细胞肿瘤的观察性研究:危险因素、诊断、治疗和结局。
PLoS One. 2020 Aug 11;15(8):e0237453. doi: 10.1371/journal.pone.0237453. eCollection 2020.
4
Epidemiology of invasive ocular surface squamous neoplasia in Canada during 1992-2010.1992-2010 年加拿大侵袭性眼表鳞状细胞肿瘤的流行病学。
Br J Ophthalmol. 2020 Oct;104(10):1368-1372. doi: 10.1136/bjophthalmol-2019-314650. Epub 2020 Jan 16.
5
Update on pharmacotherapy for ocular surface squamous neoplasia.眼表鳞状上皮肿瘤药物治疗的最新进展
Eye Vis (Lond). 2019 Aug 12;6:24. doi: 10.1186/s40662-019-0150-5. eCollection 2019.
6
A prospective study of the incidence, associations and outcomes of ocular surface squamous neoplasia in the United Kingdom.一项关于英国眼表鳞状上皮肿瘤的发病率、相关性和结局的前瞻性研究。
Eye (Lond). 2019 Feb;33(2):283-294. doi: 10.1038/s41433-018-0217-x. Epub 2018 Dec 28.
7
Comparison of Topical 5-Fluorouracil and Interferon Alfa-2b as Primary Treatment Modalities for Ocular Surface Squamous Neoplasia.眼表面鳞状上皮肿瘤的局部 5-氟尿嘧啶和干扰素 Alfa-2b 作为主要治疗方式的比较。
Am J Ophthalmol. 2019 Mar;199:216-222. doi: 10.1016/j.ajo.2018.11.007. Epub 2018 Nov 22.
8
High-Resolution Anterior Segment Optical Coherence Tomography in Intraepithelial Versus Invasive Ocular Surface Squamous Neoplasia.高分辨率眼前节光学相干断层扫描在眼表上皮内与浸润性鳞状细胞癌中的应用
Cornea. 2018 Oct;37(10):1292-1298. doi: 10.1097/ICO.0000000000001680.
9
Ultraviolet radiation oxidative stress affects eye health.紫外线辐射氧化应激会影响眼部健康。
J Biophotonics. 2018 Jul;11(7):e201700377. doi: 10.1002/jbio.201700377. Epub 2018 Apr 24.
10
Mitomycin C or interferon as adjuvant therapy to surgery for ocular surface squamous neoplasia: comparative study.丝裂霉素C或干扰素作为眼表鳞状上皮肿瘤手术辅助治疗的比较研究。
Eur J Ophthalmol. 2018 Mar;28(2):204-209. doi: 10.5301/ejo.5001035. Epub 2017 Nov 9.